{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThis study explores the role of lincRNA ZNF529‐AS1, a recently identified tumour‐associated molecule that is differentially expressed in various cancers, in the context of hepatocellular carcinoma (HCC). The investigation focuses on determining its expression patterns and functional implications, particularly regarding HCC invasion and metastasis—a primary cause of poor prognosis in affected patients. Although the precise mechanisms by which ZNF529‐AS1 mediates these processes remain to be fully elucidated, the research aims to clarify its contribution to tumour progression and evaluate its potential utility as a prognostic biomarker in HCC."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yang Ma, Wan-Liang Sun, Shuo Shuo Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Bioinformatics (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12859-023-05189-0"}], "href": "https://doi.org/10.1186/s12859-023-05189-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36803542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36803542"}]}]}]}